Altered states: the clinical effects of Ecstasy. (Q35095703)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Altered states: the clinical effects of Ecstasy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J C Cole

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

Pharmacology & Therapeutics

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

35-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

Peripheral hormonal responses to D -fenfluramine as a probe of central serotonergic function in humans

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy: a common cause of severe acute hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Intentional overdose and death with 3,4-methylenedioxyethamphetamine (MDEA; "Eve"): case report

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Pharmacology and effects of cannabis: a brief review

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chemical analysis of ecstasy pills

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychobiology of novelty seeking and drug seeking behavior

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Composition profiling of seized ecstasy tablets by Raman spectroscopy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychiatric illness associated with "ecstasy".

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The neuropsychiatry of chronic cocaine abuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hyponatraemia at a rave

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Polydrug use at raves by a Western Australian sample

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cardiovascular autonomic dysregulation in users of MDMA ("Ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Urinary retention with misuse of "ecstasy"

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Amphetamine derivative fatalities in South Australia--is "Ecstasy" the culprit?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The BDI of the beholder

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The content of ecstasy tablets: implications for the study of their long-term effects.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

What is a dose of ecstasy?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Methodological problems with ecstasy and the SCL-90.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

‘Ecstasy’ Psychosis and Flashbacks

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Carrier-dependent and Ca(2 )-dependent 5-HT and dopamine release induced by ( )-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and ( )-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The relative contributions of ecstasy and cannabis to cognitive impairment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Fatal MDMA intoxication

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Pharmacology of MDMA in Humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hair testing for "ecstasy" (MDMA) in volunteer Scottish drug users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy induced hepatitis mimicking viral hepatitis

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute liver damage and ecstasy ingestion

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Drug workers emphasise that water is not an antidote to drug

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug ( /-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Pre-exposure to ( /-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of MDMA on complex brain function in laboratory animals

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Mood state and brain electric activity in ecstasy users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroendocrine responses of healthy volunteers to `techno-music': relationships with personality traits and emotional state

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Long-lasting effects of ( /-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The serotonin syndrome and its treatment

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Subarachnoid haemorrhage associated with MDMA abuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

1 reference

7 January 2021

Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Fatal uncertainty: death-rate from use of ecstasy or heroin

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam-phetamine)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroendocrine and cardiovascular effects of MDE in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Drug abusers show impaired performance in a laboratory test of decision making.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Subjective reports of the effects of MDMA in a clinical setting

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Can drugs be used to enhance the psychotherapeutic process?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Deconstructing Ecstasy: The Politics Of Mdma Research

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

An unusual case of Ecstasy poisoning

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Do hallucinogens cause residual neuropsychological toxicity?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A concealed cause of recurrent renal failure in a patient with juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA. The dark side of ecstasy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonin transporters in ecstasy users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Auxiliary liver transplantation for acute liver failure after intake of 3,4-methylenedioxymethamphetamine ("Ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Fatal interaction between ritonavir and MDMA

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Low-dose MDMA ("ecstasy") induces vasopressin secretion

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hyponatraemia and seizures after ecstasy use.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Retinal haemorrhage caused by "ecstasy".

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA elicits behavioral and neurochemical sensitization in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Rhabdomyolysis and shock after intravenous amphetamine administration

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hyponatraemia after ingestion of ecstasy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chemistry and pharmacology of hallucinogens, entactogens and stimulants

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Delayed severe rhabdomyolysis after taking 'ecstasy'.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Gender differences in the subjective effects of MDMA.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Amphetamine derivative related deaths

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cerebral infarction in association with Ecstasy abuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cerebral oedema after ingestion of MDMA ("ecstasy") and unrestricted intake of water

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hyponatraemia and catatonic stupor after taking "ecstasy".

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA ("ecstasy") and panic disorder: induction by a single dose

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Caveat emptor: editors beware

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

"Ecstasy" and serotonin neurotoxicity: new findings raise more questions

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonin neurotoxicity after ( /-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive performance in ( /-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Long term psychiatric and cognitive effects of MDMA use.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Flashbacks following MDMA

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Some behavioural and neurochemical aspects of subacute ( /-)3,4-methylenedioxymethamphetamine administration in rats

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Drinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Pathology of deaths associated with "ecstasy" and "eve" misuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens:

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Risk factors for drug use among adolescents: concurrent and longitudinal analyses.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Panic attacks. A neurochemical overview of models and mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hippocampal 1H-MRSI in ecstasy users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA (Ecstasy) precipitation of panic disorder

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Lack of serotonin neurotoxicity after intraraphe microinjection of ( )-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A new method to monitor drugs at dance venues

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

An association between the regular use of 3,4 methylenedioxy-methamphetamine (ecstasy) and excessive wear of the teeth

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

( /-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Patterns of recreational drug use at dance events in Edinburgh, Scotland

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

1 reference

7 January 2021

Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive performance amongst recreational users of "ecstasy".

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive effects of cocaine and polydrug abuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Inhibitory dysfunction in hyperactive boys

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chronic atypical psychosis associated with MDMA ("ecstasy") abuse

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Is the use of ecstasy and hallucinogens increasing? Results from a community study

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Fatal MDMA intoxication

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Immunocytochemical evidence for serotonergic neurotoxicity of N-ethyl-methylenedioxyamphetamine (MDE).

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychiatric complications of 'Ecstasy' use

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

1 reference

7 January 2021

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

MDMA. Nonmedical use and intoxication

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

A case of MAO inhibitor/MDMA interaction: agony after ecstasy

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute and subchronic effects of methylenedioxymethamphetamine [( /-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

"Ecstasy" and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Substance dependence, family history of alcohol dependence and neuropsychological functioning in adolescence.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Ecstasy use in Australia: patterns of use and associated harm

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

'Is MDMA a human neurotoxin?': diverse views from the discussants

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The complications of 'ecstasy' (MDMA)

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cognitive performance and serotonergic function in users of ecstasy.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Disruption of the discriminative stimulus effects of S( )-3,4-methylenedioxymethamphetamine (MDMA) by ( /-)-MDMA neurotoxicity: protection by fluoxetine.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Caveat emptor: editors beware

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Fatal multi-organ failure after suicidal overdose with MDMA, 'ecstasy': case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Working memory deficits in current and previous users of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Patterns of alcohol consumption, smoking and illicit drug use in British university students: interfaculty comparisons

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

An update on British medical students' lifestyles

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Lethal monointoxication by overdosage of MDEA.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Hyponatraemia must be treated with low water input

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

"Saturday night fever": ecstasy related problems in a London accident and emergency department

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Adverse effects of stimulant drugs in a community sample of drug users.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Chronic paranoid psychosis after misuse of MDMA

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Contents of "ecstasy"

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Knowledge and experience of young people regarding drug misuse, 1969-94.

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Neuroendocrine probes of serotonergic function: a critical review

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

"Loss of control" in alcoholism and drug addiction: a neuroscientific interpretation

1 reference

https://api.crossref.org/works/10.1016/S0163-7258(03)50003-2

7 January 2021

10.1016/S0163-7258(03)00003-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12667887 AND SRC:MED&resulttype=core&format=json

2 November 2019

1 reference